The Competition Board concluded the preliminary inquiry, which was conducted upon the claim that Align Tech Turkey Tıbbi Cihazlar Limited Şirketi has abused its dominant position by means of unfair and predatory pricing and violated Article 6 of the Act no 4054 on the Protection of Competition.
Having discussed the information and documents acquired, and observations made in the preliminary inquiry in its meeting dated 18.05.2022, the Competition Board considered that the findings were significant and sufficient, and took the decision numbered 22-23/368-M to initiate an investigation about Align Tech Turkey Tıbbi Cihazlar Limited Şirketi.

*Investigation decisions taken by the Competition Board are announced to the public after the decision is notified to the undertakings or associations of undertakings about which an investigation has been initiated. Those announcements are made within the framework of informing the public about the decisions of the Competition Board and cannot be interpreted to mean that the undertakings or associations of undertakings under investigation violated the Act no 4054, or they are or will be subject to penal sanctions under the Act.